Literature DB >> 7745116

p53, Rb and bcl-2 expression during the cell cycle: a study in phytohaemagglutinin stimulated lymphocytes and microwave irradiated lymphoid tissue sections.

M S Mateo1, M Sanchez-Beato, J C Martinez, A Orfao, J L Orradre, M A Piris.   

Abstract

AIMS: To determine the expression of p53, Rb, and bcl-2 during the cell cycle in stimulated peripheral blood lymphocytes (PBLs) and microwave heated reactive lymphoid tissue sections.
METHODS: The expression of p53, Rb and bcl-2 proteins in paraffin wax embedded tonsil tissue sections was detected by immunohistochemistry using an (APAAP) technique following microwave irradiation. Flow cytometric analysis as performed on phytohaemagglutinin (PHA) stimulated PBLs, with simultaneous S fraction determination.
RESULTS: Expression of p53 protein was detected in reactive tonsil germinal centre cells, in some suprabasal cells in the surface and cryptic epithelium, and in some endothelial cells. Analysis of p53 in PHA stimulated PBLs revealed expression of p53 by non-tumoral activated lymphocytes. Rb protein expression was increased in PHA stimulated PBLs and was usually detected in most germinal centre B cells, in isolated paracortical cells, in a fraction of endothelial cells, and in most epithelial suprabasal cells. Expression of bcl-2 in stimulated lymphocytes was inversely correlated with proliferation. This confirms findings in reactive tonsil tissue samples, where proliferating cells located in the germinal centres and paracortical area are mostly bcl-2 negative.
CONCLUSIONS: Expression of these three oncogenic and tumour suppressor proteins varies during the cell cycle in non-tumoral cells. Consequently, tumoral growth fraction must be taken into account when analysing dysregulation of these three genes in lymphomas and other tumours. The p53 protein may be detected in benign conditions, as its expression is not synonymous with malignancy or mutation of the p53 gene.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7745116      PMCID: PMC502390          DOI: 10.1136/jcp.48.2.151

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  41 in total

1.  Effects of an Rb mutation in the mouse.

Authors:  T Jacks; A Fazeli; E M Schmitt; R T Bronson; M A Goodell; R A Weinberg
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

Review 2.  Molecular biology of the human retinoblastoma gene.

Authors:  W H Lee; R E Bookstein; E Y Lee
Journal:  Immunol Ser       Date:  1990

3.  Flow cytometric detection of the mitochondrial BCL-2 protein in normal and neoplastic human lymphoid cells.

Authors:  A Aiello; D Delia; M G Borrello; D Biassoni; R Giardini; E Fontanella; F Pezzella; K Pulford; M Pierotti; G Della Porta
Journal:  Cytometry       Date:  1992

4.  Participation of p53 protein in the cellular response to DNA damage.

Authors:  M B Kastan; O Onyekwere; D Sidransky; B Vogelstein; R W Craig
Journal:  Cancer Res       Date:  1991-12-01       Impact factor: 12.701

5.  P53 protein expression in lymphomas and reactive lymphoid tissue.

Authors:  R Villuendas; M A Piris; J L Orradre; M Mollejo; P Algara; L Sanchez; J C Martinez; P Martinez
Journal:  J Pathol       Date:  1992-03       Impact factor: 7.996

6.  Requirement for a functional Rb-1 gene in murine development.

Authors:  A R Clarke; E R Maandag; M van Roon; N M van der Lugt; M van der Valk; M L Hooper; A Berns; H te Riele
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

7.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis.

Authors:  E Y Lee; C Y Chang; N Hu; Y C Wang; C C Lai; K Herrup; W H Lee; A Bradley
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

8.  Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6.

Authors:  E Yonish-Rouach; D Resnitzky; J Lotem; L Sachs; A Kimchi; M Oren
Journal:  Nature       Date:  1991-07-25       Impact factor: 49.962

9.  Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level.

Authors:  H J Xu; S X Hu; W F Benedict
Journal:  Oncogene       Date:  1991-07       Impact factor: 9.867

10.  Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma.

Authors:  F Pezzella; M Jones; E Ralfkiaer; J Ersbøll; K C Gatter; D Y Mason
Journal:  Br J Cancer       Date:  1992-01       Impact factor: 7.640

View more
  5 in total

1.  Detection of p53 in inflammatory tissue and lymphocytes using immunohistology and flow cytometry: a critical comment.

Authors:  A Nickels; H Selter; M Pfreundschuh; M Montenarh; B Koch
Journal:  J Clin Pathol       Date:  1997-08       Impact factor: 3.411

2.  Should superheating be used for immunohistochemistry?

Authors:  H A Lambkin; C Mothersill
Journal:  J Clin Pathol       Date:  1995-09       Impact factor: 3.411

3.  Genes mediating programmed cell death: an immunohistochemical study of bcl-2, c-myc and p53 expression in colorectal neoplasia.

Authors:  N Scott; I Martin; A S Jack; M F Dixon; P Quirke
Journal:  Clin Mol Pathol       Date:  1996-06

4.  Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells.

Authors:  Marc R Theoret; Cyrille J Cohen; Azam V Nahvi; Lien T Ngo; Kimberly B Suri; Daniel J Powell; Mark E Dudley; Richard A Morgan; Steven A Rosenberg
Journal:  Hum Gene Ther       Date:  2008-11       Impact factor: 5.695

5.  Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression.

Authors:  M Sánchez-Beato; J C Martínez-Montero; T A Doussis-Anagnostopoulou; K C Gatter; J García; J F García; E LLoret; M A Piris
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.